5-Year Outcomes with Cobimetinib plus Vemurafenib in <i>BRAF</i> V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study
2021 · Clinical Cancer Research · 175 citations
https://doi.org/10.1158/1078-0432.ccr-21-0809
H
Haocheng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
1.6K
Citations
21
h-index
38
i10-index
Haocheng Li is an academic researcher from University of Calgary. The author has contributed to research in topics: Statistical Methods and Bayesian Inference & Statistical Methods and Inference & Lung Cancer Treatments and Mutations. The author has an h-index of 21, co-authored 81 publications.
ORCID: 0000-0003-4858-6509Papers by this author
worksCentral Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs
2018 · Clinical Cancer Research · 111 citations
https://doi.org/10.1158/1078-0432.ccr-18-2366
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry
2019 · The Oncologist · 68 citations
https://doi.org/10.1634/theoncologist.2019-0446
The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer
2018 · PLoS ONE · 53 citations
https://doi.org/10.1371/journal.pone.0188983
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs
2019 · Clinical Cancer Research · 29 citations
https://doi.org/10.1158/1078-0432.ccr-19-2350
Strong and Thermo‐Switchable Gel Adhesion Based on UCST‐Type Phase Transition in Deep Eutectic Solvent
2024 · Advanced Science · 26 citations
https://doi.org/10.1002/advs.202400938
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat